[1] Rafieian-Kopaei M, Setorki M, Doudi M, et al. Atherosclerosis: process, indicators, risk factors and new hopes[J]. Int J Prev Med, 2014, 5(8):927-946.
[2] Wang S, Xu J, Zheng J, et al. Anti-inflammatory and antioxidant effects of acetyl-l-carnitine on atherosclerotic rats[J]. Med Sci Monit, 2020, 26:e920250. DOI: 10.12659/MSM.920250.
[3] Funk CD, Cyrus T. 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis[J]. Trends Cardiovasc Med, 2001, 11(3-4):116-124. DOI: 10.1016/s1050-1738(01)00096-2.
[4] Steinberg D. Low density lipoprotein oxidation and its pathobiological significance[J]. J Biol Chem, 1997, 272(34):20963-20966. DOI: 10.1074/jbc.272.34.20963.
[5] Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance[J]. Nat Rev Immunol, 2013, 13(10):709-721. DOI: 10.1038/nri3520.
[6] Bobryshev YV, Ivanova EA, Chistiakov DA, et al. Macrophages and their role in atherosclerosis: pathophysiology and transcriptome analysis[J]. Biomed Res Int, 2016, 2016:9582430. DOI: 10.1155/2016/9582430.
[7] Yan Y, Song D, Wu J, et al. Long non-coding RNAs link oxidized low-density lipoprotein with the inflammatory response of macrophages in atherogenesis[J]. Front Immunol, 2020, 11:24. DOI: 10.3389/fimmu.2020.00024.
[8] Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases[J]. Front Immunol, 2014, 5:491. DOI: 10.3389/fimmu.2014.00491.
[9] Legein B, Temmerman L, Biessen EA, et al. Inflammation and immune system interactions in atherosclerosis[J]. Cell Mol Life Sci, 2013, 70(20):3847-3869. DOI: 10.1007/s00018-013-1289-1.
[10] Ramji DP, Davies TS. Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets[J]. Cytokine Growth Factor Rev, 2015, 26(6):673-685. DOI: 10.1016/j.cytogfr.2015.04.003.
[11] Ribeiro F, Alves AJ, Duarte JA, et al. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? [J]. Int J Cardiol, 2010, 141(3):214-221. DOI: 10.1016/j.ijcard.2009.09.548.
[12] Hambrecht R, Walther C, Möbius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial[J]. Circulation, 2004, 109(11):1371-1378. DOI: 10.1161/01.CIR.0000121360.31954.1F.
[13] Thompson PD. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease[J]. Arterioscler Thromb Vasc Biol, 2003, 23(8):1319-1321. DOI: 10.1161/01.ATV.0000087143.33998.F2.
[14] Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise[J]. J Appl Physiol (1985), 2005, 98(4):1154-1162. DOI: 10.1152/japplphysiol.00164.2004.
[15] 程金凤,王倩倩,甄萌萌,等.生物钟基因Cry1与动脉粥样硬化相关性研究进展[J].国际医药卫生导报,2022,28(10):1343-1346. DOI:10.3760/cma.j.issn.1007-1245.2022. 10.003.
[16] Shakoor H, Platat C, Ali HI, et al. The benefits of physical activity in middle-aged individuals for cardiovascular disease outcomes[J]. Maturitas, 2023, 168:49-52. DOI: 10.1016/j.maturitas.2022.11.002.
[17] Sun Y, Wu Y, Jiang Y, et al. Aerobic exercise inhibits inflammatory response in atherosclerosis via Sestrin1 protein[J]. Exp Gerontol, 2021, 155:111581. DOI: 10.1016/j.exger.2021.111581.
[18] Yang L, Chu Y, Wang L, et al. Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NF-κB pathway[J]. Int Immunopharmacol, 2015, 28(1):525-530. DOI: 10.1016/j.intimp.2015.07.001.
[19] Ross R. Atherosclerosis--an inflammatory disease[J]. N Engl J Med, 1999, 340(2):115-126. DOI: 10.1056/NEJM199901143400207.
[20] Qamar A, Rader DJ. Effect of interleukin 1β inhibition in cardiovascular disease[J]. Curr Opin Lipidol, 2012, 23(6):548-553. DOI: 10.1097/MOL.0b013e328359b0a6.
[21] Ku EJ, Kim BR, Lee JI, et al. The anti-atherosclerosis effect of anakinra, a recombinant human interleukin-1 receptor antagonist, in apolipoprotein E knockout mice[J]. Int J Mol Sci, 2022, 23(9):4906. DOI: 10.3390/ijms23094906.
[22] Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6[J]. J Immunol, 2005, 175(6):3463-3468. DOI: 10.4049/jimmunol.175.6.3463.
[23] Teng Z, Wei M. Correlation between serum 25-hydroxyvitamin D level and coronary heart disease[J]. Am J Transl Res, 2021, 13(7):8379-8384.
[24] 胡丰林.RBP4、hs-CRP、IL-6水平检测在冠心病病情评估中的应用[J].中国民康医学,2022,34(7):126-129. DOI:10.3969/j.issn.1672-0369.2022.07.039.
[25] Munjal A, Khandia R. Atherosclerosis: orchestrating cells and biomolecules involved in its activation and inhibition[J]. Adv Protein Chem Struct Biol, 2020, 120:85-122. DOI: 10.1016/bs.apcsb.2019.11.002.
[26] Wu W, Wang H, Jiao G, et al. Aerobic exercise suppresses atherosclerosis through adiponectin-nuclear transcription factor κB pathway in apolipoprotein E-deficient mice[J]. Am J Med Sci, 2017, 353(3):275-281. DOI: 10.1016/j.amjms.2016.11.002.
[27] Narasimamurthy R, Hatori M, Nayak SK, et al. Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines[J]. Proc Natl Acad Sci U S A, 2012, 109(31):12662-12667. DOI: 10.1073/pnas.1209965109.
|